Assessing Risk Factors for Radiological Complications After Transforaminal Lumbar Interbody Fusion
AgeTLIF
AgeTLIF - Assessing Risk Factors for Radiological Complications After Transforaminal Lumbar Interbody Fusion
1 other identifier
observational
170
1 country
1
Brief Summary
This retrospective study is to determine whether age is a risk factor for postoperative complications in patients undergoing transforaminal lumbar interbody fusion; specifically whether the risk (odds) of implant failure and the need for revision surgery increases with age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2022
CompletedFirst Submitted
Initial submission to the registry
February 23, 2022
CompletedFirst Posted
Study publicly available on registry
March 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2023
CompletedFebruary 20, 2024
February 1, 2024
4 months
February 23, 2022
February 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Implant failure
Number of Implant failure (screw loosening, cage subsidence, adjacent level alteration/ degeneration, spondylolisthesis degree, kyphosis of the adjacent intervertebral disc space, reduced height of intervertebral disc space) in relationship to age
one time assessment at baseline
Number of patients needing revision surgery
Number of patients needing revision surgery, in relationship to age
one time assessment at baseline
Interventions
Collection of medical data and medical images (MRI, radiographs) of the lumbar spine and pelvis of patients having received TLIF with degenerative spinal diseases from the years 2015-2020 and statistical analysis of the coded data.
Eligibility Criteria
All patients who received TLIF at the age of 55 years or older at the University Hospital Basel between 01.01.2015 and 1.07.2020.
You may qualify if:
- Indications for TLIF surgery (e.g., degenerative disc disease, spondylolisthesis)
- Existing preoperative upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis, sacrum and femoral head
- Existing preoperative MRI of the lumbar region with clear visibility of different fatty infiltration grade and stenosis degree
- Complete follow-up at 3 months and 1 year postoperatively, including clinical and radiographic data
You may not qualify if:
- Neuromuscular diseases such as Parkinson's disease or multiple sclerosis according to our records
- Preoperative infection and/or malignancy tumor with involvement of the bony or soft tissue structures of the lumbar spine
- Presence of a documented consent dissent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Basel, Orthopedics and Traumatology
Basel, 4031, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cordula Netzer, PD Dr. med.
University Hospital Basel, Clinic for Orthopedics and Traumatology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2022
First Posted
March 4, 2022
Study Start
January 19, 2022
Primary Completion
May 5, 2022
Study Completion
February 15, 2023
Last Updated
February 20, 2024
Record last verified: 2024-02